SCHEMBL21362581

SCHEMBL21362581

C=C(c1ccc(Cl)cc1)c1cc(F)ccc1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANO1 Q5XXA6 1/20 0.40
MDM2 Q00987 11/20 0.40
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
GABRP O00591 2/20 0.36
GABRD O14764 2/20 0.36
GABRA1 P14867 2/20 0.36
GABRB1 P18505 2/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA5 P31644 2/20 0.36
GABRA3 P34903 2/20 0.36
GABRA2 P47869 2/20 0.36
GABRB2 P47870 2/20 0.36
GABRA4 P48169 2/20 0.36
GABRE P78334 2/20 0.36
GABRA6 Q16445 2/20 0.36
GABRG1 Q8N1C3 2/20 0.36
GABRG3 Q99928 2/20 0.36
GABRQ Q9UN88 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20158110 0.80 MDM2 (0.46) ANO1MDM2NPC1RAB9ACES2
SCHEMBL10705376 0.76 HTT (0.46) NPC1RAB9ACES2CES1SMN1; SMN2
SCHEMBL20157673 0.73 RXRA (0.35) RXRASMN1; SMN2MAOB
SCHEMBL10704841 0.72 FLT1 (0.47) NPC1RAB9AGABRA1GABRB1GABRG2
SCHEMBL31619553 0.72 ALDH1A1 (0.46) NPC1RAB9ACES2CES1SMN1; SMN2
SCHEMBL15974805 0.71 F2R (0.38) ANO1CES2CES1TDP1
SCHEMBL31619554 0.69 NPC1 (0.42) NPC1RAB9ACES2CES1RXRA
SCHEMBL20560231 0.69 CES2 (0.39) ANO1NPC1CES2CES1SMN1; SMN2
SCHEMBL1796583 0.69 MAPT (0.55) CES2CES1MAOB
SCHEMBL9422059 0.68 TP53 (0.47) ANO1NPC1RAB9AGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed